Previous studies in Euro-American countries have shown that patients with chronic hepatitis C virus infection have increased levels of neuropsychiatric symptoms. While chronic hepatitis C virus infection has been reported in Arab countries such as Iraq, there is little studies about the neuropsychological burden associated with chronic hepatitis C among patients in the Arab region. The aim of the current study was to measure the prevalence and level of severity of depression, anxiety and stress among a sample of chronic hepatitis C patients in AL-Najaf province /Iraq.The current study was cross-sectional study carried out on (110) already diagnosed chronic viral hepatitis C patients who attended the Gastroenterology and Hepatology Center/Al-Sader Medical City/Najaf/Iraq during November 2018 to May 2019. In addition, (100) apparently healthy subjects were included as a control group.The Arabic version of the Depression Anxiety Stress Scale (DASS-21) was used to assess mental health.Both the prevalence rates and severity levels of depression, anxiety and stress were signi icantly higher in chronic hepatitis C patients compared to the control group (P<0.001). Stress level is negatively correlated with age and is signi icantly more in single. Anxiety level is less with a higher level of education. Depression was signi icantly higher in those having children. The study indicates that the presence of chronic hepatitis C infection is associated with a higher risk of psychological burden. Accordingly, meeting the psychological needs of such patients would need to be addressed.
INTRODUCTION
Hepatitis C virus (HCV) is a major blood-borne infection. There are about 120-130 million or 3% of the world population that is infected with HCV. According to the World Health Organization (WHO), there are approximately 3-4 million new cases of HCV infection annually (Morozov and Lagaye, 2018) . It is a leading cause of hepatic morbidity and mortality by its predisposition to liver cirrhosis, ibrosis, and hepatocellular carcinoma (HCC). Yearly, hepatitis C causes about 399,000 deaths worldwide, mostly from cirrhosis and HCC (Renau and Berenguer, 2018) . In Iraq, hepatitis C is considered of low endemicity. The prevalence of anti-HCV was low (0.4%) (Tarky et al., 2005) .
Rates of depression have been reported in the range of 22 -59% of patients with hepatitis C (Majeed et al., 2009; Gill et al., 2005; Gleason et al., 2005; Memon et al., 2011) .
Anxiety is another problem experienced by many patients with HCV. One study showed that 24% of patients with HCV had anxiety (Golden et al., 2005) . Most researches regarding anxiety show that it is at least as common as depression (Fontana et al., 2002; Loftis et al., 2006; Yovtcheva et al., 2001; El-Serag et al., 2002) . Knowing that one has acquired a serious infection such as HCV, with its complications is a major life stressor, and will produce emotional stress in most, and neuropsychiatric disorder in many (Wessely and Pariante, 2002) .
Psychiatric disorders are important in patients with hepatitis virus infection for their in luence on daily function of hepatitis positive patients by increasing their extrahepatic manifestations (Obhrai et al., 2001) . They also can decrease health-related quality of life (HRQOL) (Fontana, 2001; Hussain, 2001) , increase the risk of cancer, mortality (Garssen and Goodkin, 1999) and suicide attack probability (Dieperink, 2000; Alavian and Hajarizadeh, 2004) in these patients. Patients with psychiatric disorders have the least compliance to drug therapy which increases the risk of treatment failure in the affected patients (Bernstein et al., 2002; Kraus et al., 2001) .
Evaluation for psychiatric symptoms in hepatitis is important because they have an adverse effect upon the course of the disease (Gadit, 2010) . These psychiatric symptoms are the major reason for delay or stopping of treatment (Zdilar et al., 2000) . Successful medical treatment, therefore, requires detection and management of depression and other psychiatric issues before and during the treatment (Dogar et al., 2009) .
The aim of the current study was to measure the prevalence and level of severity of depression, anxiety and stress among a sample of chronic hepatitis C patients in AL-Najaf province/Iraq.
PATIENTS AND METHOD

Patients
The current cross-sectional study was carried out on (110) already diagnosed chronic viral hepatitis C patients who attended the Gastroenterology and Hepatology center/Al-Sader Medical City/Najaf during November 2018 to May 2019. In addition, 100 apparently healthy subjects were included as a control group.
Inclusion criteria
The inclusion criteria for the current study were:
1. Patients having chronic hepatitis C alone, who are aged 18 years or more of either sex who are accepted to participate in the study.
2. Disease duration (since diagnosis) of at least six months or more.
Exclusion criteria
The exclusion criteria for this study were 1. Patient who had a hearing, speech or cognitive de icits that would impair understanding of the questions. 6. Patients providing incomplete information during completion of the questionnaire also will excluded from the study.
Method
The questionnaires
The Depression Anxiety Stress Scale (DASS-21) was used to assess mental health. DASS-21 is a 21item self-reported tool developed to measure the 3 related negative emotional problems, including depression, anxiety, and stress. It has 21-items, with 7 items for each domain. Patients scored each item from 0-3, where zero meant (did not apply to me at all) and 3 meant (applied to me very much). All scores of each subscale were added and multiplied by 2. The normal score for stress was 0-14, for anxiety 0-7, and for depression 0-9. The mild score for stress was 15-18, for anxiety 8-9, and depression 10-13. The moderate score for stress 19-25, for anxiety 10-14, and for depression 14-20. The severe score for stress was 26-33, for anxiety 15-19, and for depressions 21-27. The extremely severe score for stress was 34+, for anxiety 20+, and for depression 28+ (Lovibond and Lovibond, 1995) . The Arabic version of this tool has been psychometrically validated. The data related to the study were collected by the researcher herself. When the patients arrived to the hospital to made their programmed laboratory data and received their treatment, they were asked if they accept to participate in the study, if they accepted to participate, a complete explanation to the questions in the questionnaire was done and each patient spent about 5 minutes to ill the research questionnaire completely.
Administration of questionnaires
Statistical analysis
Data were collected, summarized, analyzed using two software programs, statistical package for social sciences (SPSS) version 23 and Microsoft Of ice Excel 2010. Categorical variables were presented as number and percentage. Quantitative variables were initially analyzed for normality distribution Kolmogorov-Smirnov test. Therefore, quantitative variables were described as mean ± standard deviation or median (interquartile range). Comparison of mean values between any two groups carried out using independent sample t-test. Association between any two categorical variables was done using Chi-square test. Spearman correlation test was used to assess variables. P-value was considered signi icant when it is equal or less than 0.05 and highly signi icant when it is equal or less than 0.01.
RESULTS AND DISCUSSION
Demographic characteristics of patients with hepatitis C and control subjects are shown in Table 1 . While the disease characteristics and investigations in patients with HCV infection are shown in Table 2 .
The prevalence rates of depression, anxiety and stress in control and HCV groups are shown in Table 3 . For depression, anxiety and stress, the differences were highly signi icant between hepatitis c group and control group (P<0.001).
The levels of severity of depression, anxiety and stress among study groups are shown in Table 4 . For depression, anxiety and stress, the differences were highly signi icant between hepatitis c group and control group (P<0.001).
Correlations of DASS domain to demographic characteristics of patients with HCV are shown in Table 5 . Stress level is negatively correlated with age, and is signi icantly more in single. Anxiety level is less with higher level of education. Depression was signi icantly higher in those having children.
Correlations of DASS domain to disease characteristics of patients with HCV are shown in Table 6 .
Depression, anxiety and stress levels were not correlated to any of disease characteristics.
Several studies had shown that patients with HCV infection tend to be associated with increased levels of emotional distress (Fontana et al., 2002; Forton, 2002; Bonkovsky and Woolley, 1999) . Most of the studies have generally conducted on Euro-American patients. To our knowledge, there are little studies from the Arabic-speaking countries. To ill this gap, this study was conducted to compare the prevalence and severity of depression, anxiety and stress as de ined by DASS-21of those diagnosed with chronic HCV infection with those without.
Both the prevalence rates and severity levels of depression, anxiety and stress were signi icantly higher in chronic hepatitis C patients compared to control. In a cross-sectional study of eighty, one HCV-infected patient who were not treated by antiviral therapy, anxiety, depression, neuropsychiatric symptoms were assessed (Erim et al., 2010) . It was found that depression and anxiety scores were signi icantly higher among HCV patients compared to the healthy control group (Erim et al., 2010) .
In a previous Italian report, 36.7% of HCV patients were found to have a psychiatric disorder (Taruschio et al., 1996) . Another study (Hunt et al., 1997) , found the rate of depression to be 11%-30% in HCV patients. Almost 25% of HCV infected patients referred for treatment were found to suffer from depression, with 60% of them requiring treatment (Lee et al., 1997) .
Two distinct types of evidence support the association between depression and HCV infection. First, patients with neuropsychiatric disorders have a higher rate of HCV infection. Second, patients with chronic HCV infection may have a higher rate of neu- ropsychiatric disorders, including depression. The prevalence of HCV is higher in patients with neuropsychiatric disorders than in healthy control. In intravenous drug users, 74% -100% of individuals are infected with HCV (Bell et al., 1990; Fingerhood, 1993; Wood ield et al., 1994; Fisher et al., 1997) .
The reasons for the high prevalence of depression in HCV infected patients are not fully understood, but two factors are important. First, HCV-infected patients are relatively younger age (the highest rate is in the 3 rd and 4 th decades of life) (Sarbah and Younossi, 2000) and may suffer from depression related to excess fatigue or worries about the longterm prognosis; they have more somatic complaints than patients having other liver diseases (Singh et al., 1997) . Secondly, HCV-infected patients may have additional risk factors for depression, such as substance abuse (Johnson et al., 1998) . From these data, it is increasingly evident that HCV infection, depression, and substance abuse are intimately related and clinically important. Depression may impair the HRQOL of patients infected with HCV infection (Dusheiko, 1997) . Also, Interferon (IFN) therapy may aggravate the symptoms of those with underlying depression, (Otsubo et al., 1997) reducing adherence, and the preexisting depressive disorders may affect with the assessment of IFN-induced depression (Johnson et al., 1998) .
Regarding the correlation of DASS-21 with demo-graphic characteristics of patients, the current study showed that stress level is signi icantly high in young, and single patients. Also, the anxiety level is signi icantly high in low educated patients. Benjamin et al. found that education and relationship status (partnered) were independent predictors of decreased anxiety while age was a signi icant predictor of decreased depression among chronic hepatitis C Australian patients (Stewart et al., 2015) .
Furthermore, in the current study, depression level was signi icantly high in patients with a high number of children, and this may be due to fearfulness of patients from disease transmission to their children. Also, there are no correlations between DASS-21 domains with disease characteristics. Seyed et al. found that in patients with viral hepatitis B or C, both anxiety and depression score were correlated with total serum bilirubin level, and AST level while depression score (but not anxiety score) was correlated with serum ALT level (Seyed et al., 2007) .
CONCLUSION
Showing attention to some limitations of our study regarding the planning process could be helpful for future studies. One limitation is the relatively small sample size collected from one Iraqi province (AL-Najaf) that could limit our ability to generalize the results to all chronic hepatitis C patients in Iraq. Future study about the same topic can be conducted as multi-center studies to enrol patients from different centers in Iraq. Another limitation is the cross-sectional design of this study rather than prospective which allow studying the effect of treatment on neuropsychiatric symptoms associated with chronic hepatitis C. In conclusion, our sample of chronic hepatitis C patients show significantly higher prevalence rate and severity levels of depression, anxiety and stress compared to control healthy subjects. These results could prove useful for health-care providers treating chronic hepatitis C patients. In addition to medical treatments that aim to cure chronic hepatitis C infection, it is important to adopt psychological counseling to further improve the HRQOL of chronic hepatitis C patients.
